The core team at 3E Bioventures Capital consists of members with biomedical backgrounds and healthcare industry experience. They have successfully invested in various areas such as drug, device, diagnostics, healthcare IT, and medical services. With their expertise and experience, they aim to capitalize on the significant growth and investment opportunities in the Chinese healthcare sector over the next 10 to 20 years, while building a strong international healthcare investment brand.